Search - tctmd.com

Displaying 1 - 20 of 400

Sort: Relevancy | Date

Presentation TCT 2025

TCT 1293: New perspectives on significant tricuspid regurgitation in patients with atrial fibrillation: left ventricular diastolic dysfunction

Presenter: Xiaochun Zhang

October 28, 2025

Presentation TCT 2025

TCT 49: Bone Morphogenetic Protein 10 (BMP-10) as a Biomarker of Post-Ablation Atrial Fibrillation

Presenter: Kuseme Udoh

October 28, 2025

Presentation TCT 2025

TCT 744: Risk of Recurrent Gastrointestinal Bleeding in Patients with Atrial Fibrillation Treated With or Without Left Atrial Appendage Occlusion: A Propensity-Matched Analysis

Presenter: Adham Ramadan

October 28, 2025

Presentation TCT 2025

TCT 50: Regional and Temporal Trends in Mortality Among Older Adults With Atrial Fibrillation and Cardiac or Vascular Device Complications in the U.S. (1999–2023), With ARIMA Forecasting

Presenter: Muhammad Zahid

October 28, 2025

Presentation TCT 2025

TCT 732: Peri-device Leak and Clinical Outcomes After LAAC Using a Fluoropolymer Coated Device in Patients with Paroxysmal vs. Persistent Atrial Fibrillation: HEAL-LAA Post Approval Study Sub-analysis

Presenter: Thomas E. Waggoner

October 28, 2025

Presentation TCT 2025

TCT 61: Comparative Analysis of Composite Outcomes for Double vs Triple Therapy in Patients with Atrial Fibrillation Post Percutaneous Coronary Intervention

Presenter: Khaled Elnaggar

October 28, 2025

Presentation TCT 2025

TCT 738: Percutaneous LAA closure in patients with non-valvular atrial fibrillation and cancer

Presenter: Carlos Eduardo Vergara Uzcategui

October 28, 2025

Presentation TCT 2025

TCT 742: Risks of Major Bleeding and Hospitalization for Falls After Left Atrial Appendage Occlusion in Patients with Atrial Fibrillation and History of Falls: A Propensity-Matched Analysis

Presenter: Mohamed Doma

October 28, 2025

Presentation TCT 2025

TCT 736: Cost Effectiveness Analysis of the OPTION Trial: Left Atrial Appendage Closure after Ablation for Non-Valvular Atrial Fibrillation

Presenter: Devi G. Nair

October 28, 2025

Presentation TCT 2025

TCT 733: CHA2DS2-VASc Score As a Predictor for Outcomes Following Left Atrial Appendage Closure Devices in Non-valvular Atrial Fibrillation; A Retrospective Analysis

Presenter: Joud Fahed

October 28, 2025

Presentation TCT 2025

TCT 713: Outcomes of Left Atrial Appendage Occlusion vs. Direct Oral Anticoagulants in Atrial Fibrillation: A Systematic Review and Meta-Analysis

Presenter: Zeyad Kholeif

October 27, 2025

Presentation TCT 2025

TCT 709: Oral Anticoagulation Versus Left Atrial Appendage Closure in Active Cancer Patients With Atrial Fibrillation: A Comparative Analysis of Safety and Efficacy

Presenter: Mehmet Cilingiroglu

October 27, 2025

Presentation TCT 2025

TCT 710: Plug It or Drug It? Left Atrial Appendage Occlusion vs Direct Acting oral Anticoagulants: A Propensity Matched Real World Analysis of 5-year Outcomes for patients with Atrial Fibrillation

Presenter: Pushan Aggarwal

October 27, 2025

Presentation TCT 2025

TCT 958: Impact of Baseline Anemia on Clinical Outcomes in Atrial Fibrillation Patients Undergoing Percutaneous Coronary Intervention

Presenter: Ravjot Singh Bhatia

October 27, 2025

Presentation TCT 2025

TCT 706: First-in-Human Evaluation of the Zenith Left Atrial Appendage Occlusion System for Stroke Prevention in High-Risk Atrial Fibrillation Patients

Presenter: Felix Mahfoud

October 27, 2025

Presentation TCT 2025

TCT 44: Procedural Outcomes of Pulsed Field Versus Radiofrequency Ablation in Persistent Atrial Fibrillation

Presenter: Mounica Vorla

October 27, 2025

Presentation TCT 2025

TCT 399: Impact of Atrial Fibrillation on Outcomes of STEMI Patients Receiving Mechanical Circulatory Support: A National Inpatient Sample Analysis from 2016–2022

Presenter: Muhammad Majid

October 27, 2025

Presentation TCT 2025

TCT 759: Use of Amiodarone for Prevention of New-Onset Atrial Fibrillation after Transcatheter Aortic Valve Replacement: PAF-TAVR Randomized Clinical Trial

Presenter: Gabriela Tirado-Conte

October 27, 2025

Presentation TCT 2025

TCT 581: Renal Sympathetic Denervation as Adjunctive Upstream Therapy during Atrial Fibrillation Ablation: Pooled Analysis of the HFIB and Ultra-HFIB Studies

Presenter: Vivek Y. Reddy

October 27, 2025

Presentation TCT 2025

TCT 585: Renal Denervation Combined with Atrial Fibrillation Ablation in Heart Failure: Interim 6-Month Data on Reverse Remodeling and Arrhythmia Recurrence

Presenter: Tomasz Skowerski

October 27, 2025

Advertisement

TCT 1293: New perspectives on significant tricuspid regurgitation in patients with atrial fibrillation: left ventricular diastolic dysfunction

TCT 49: Bone Morphogenetic Protein 10 (BMP-10) as a Biomarker of Post-Ablation Atrial Fibrillation

TCT 744: Risk of Recurrent Gastrointestinal Bleeding in Patients with Atrial Fibrillation Treated With or Without Left Atrial Appendage Occlusion: A Propensity-Matched Analysis

TCT 50: Regional and Temporal Trends in Mortality Among Older Adults With Atrial Fibrillation and Cardiac or Vascular Device Complications in the U.S. (1999–2023), With ARIMA Forecasting

TCT 732: Peri-device Leak and Clinical Outcomes After LAAC Using a Fluoropolymer Coated Device in Patients with Paroxysmal vs. Persistent Atrial Fibrillation: HEAL-LAA Post Approval Study Sub-analysis

TCT 61: Comparative Analysis of Composite Outcomes for Double vs Triple Therapy in Patients with Atrial Fibrillation Post Percutaneous Coronary Intervention

TCT 738: Percutaneous LAA closure in patients with non-valvular atrial fibrillation and cancer

TCT 742: Risks of Major Bleeding and Hospitalization for Falls After Left Atrial Appendage Occlusion in Patients with Atrial Fibrillation and History of Falls: A Propensity-Matched Analysis

TCT 736: Cost Effectiveness Analysis of the OPTION Trial: Left Atrial Appendage Closure after Ablation for Non-Valvular Atrial Fibrillation

TCT 733: CHA2DS2-VASc Score As a Predictor for Outcomes Following Left Atrial Appendage Closure Devices in Non-valvular Atrial Fibrillation; A Retrospective Analysis

TCT 713: Outcomes of Left Atrial Appendage Occlusion vs. Direct Oral Anticoagulants in Atrial Fibrillation: A Systematic Review and Meta-Analysis

TCT 709: Oral Anticoagulation Versus Left Atrial Appendage Closure in Active Cancer Patients With Atrial Fibrillation: A Comparative Analysis of Safety and Efficacy

TCT 710: Plug It or Drug It? Left Atrial Appendage Occlusion vs Direct Acting oral Anticoagulants: A Propensity Matched Real World Analysis of 5-year Outcomes for patients with Atrial Fibrillation

TCT 958: Impact of Baseline Anemia on Clinical Outcomes in Atrial Fibrillation Patients Undergoing Percutaneous Coronary Intervention

TCT 706: First-in-Human Evaluation of the Zenith Left Atrial Appendage Occlusion System for Stroke Prevention in High-Risk Atrial Fibrillation Patients

TCT 44: Procedural Outcomes of Pulsed Field Versus Radiofrequency Ablation in Persistent Atrial Fibrillation

TCT 399: Impact of Atrial Fibrillation on Outcomes of STEMI Patients Receiving Mechanical Circulatory Support: A National Inpatient Sample Analysis from 2016–2022

TCT 759: Use of Amiodarone for Prevention of New-Onset Atrial Fibrillation after Transcatheter Aortic Valve Replacement: PAF-TAVR Randomized Clinical Trial

TCT 581: Renal Sympathetic Denervation as Adjunctive Upstream Therapy during Atrial Fibrillation Ablation: Pooled Analysis of the HFIB and Ultra-HFIB Studies

TCT 585: Renal Denervation Combined with Atrial Fibrillation Ablation in Heart Failure: Interim 6-Month Data on Reverse Remodeling and Arrhythmia Recurrence

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content